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OBITUARY
Dr Alan P Wole 1959 – 2001
On May 26 of this year, Alan Wole was killed in a
trac accident. May 28th – just 2 days later – saw the
publication of his last oeuvre as an editor: an issue of
Oncogene Reviews devoted to chromatin remodeling.
On behalf of his many friends and colleagues, we oer
a tribute to the life and work of this remarkable man.
Alan would have turned 42 this year – to all those who
knew him, however, it was clear that he lived and worked
to an internal clock that used a dierent unit of time –
his actual age when converted to Earth years might well
have been a hundred. How he managed to do so much so
well in so little time is a mystery. His career began with
biophysical studies with Ian Walker on nucleosomes as
an undergraduate at Oxford University. He then went on
to study gene regulation during amphibian development
with JR Tata at the MRC in London during the early
1980s, and continued with justly famous work done with
DD Brown at the Carnegie Institute of Embryology on
the dyamics of selective 5S rDNA gene control during
development in Xenopus (one of us has very fond
memories of studying the Wole/Brown papers as
contemporary classics in a first-year graduate school
course). Alan then joined the NIH, where in a short 10
years, he managed to coordinate a strikingly productive
research eort on literally every aspect of the biology of
the nucleus. His stunning publication record of just the
last 3 years reveals an extraordinarily broad palette of
biochemical, structural, and functional studies on –
among many other topics – the role of DNA
methylation in regulating gene expression in normal
and pathological states, chromatin modification and
remodeling in transcriptional repression and activation,
transcriptional control by nuclear hormone receptors,
nuclear reprogramming, basal transcription machinery
function during early development, and the molecular
mechanisms of gene misregulation in disease, including
cancer and Rett syndrome.
Eager for the challenge of studying the newly sequence
human genome in its native form and excited at the
opportunity to apply in a functional genomics setting his
broad expertise in the biology of the nucleus, Alan spent
the last year and a half of his life in Sangamo BioSciences.
While there, he directed an eort to use synthetic
transcription factors as therapeutic agents in human
disease, in plant agriculture, and to continue dissecting
the pathways of gene control in chromatin.
The concordance of his death and the coming out of
the Oncogene review issue is tragic and poignant:
Alan’s encyclopeadic erudition was legendary – with
stunning speed and facility he retrieved from memory
references both obscure and renown. Alan’s book,
‘‘Chromatin Structure and Function’’, now in its 3rd
edition, an inimitably succint, cogent, stunningly
comprehensive and clear distillation of data from more
than 1700 references, remains, together with the many
review and primary research articles he authored, an
invaluable permanent record of his scientific achieve-
ment, his extraordinary breadth as a scholar, and his
remarkable ability for synthetic thought on a subject
where such synthesis is a dire necessity.
However deep the wound to science imparted by
Alan’s death, it pales by comparison to the enormity of
the loss to Alan’s family – his wife and his two young
children. No verbal or written condolences can possibly
do justice to the profoundity and sincerity of our
feelings of sympathy for Liz, Max and Kate.
At the request of Liz Wole, The American Cancer
Society (http://www.cancer.org), the Rett Syndrome
Research Foundation (http://www.rsrf.org), and an
educational fund for Alan’s children (http://www.san-
gamo.com/4apw) will gratefully accept donations in
Alan’s memory.
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